Menu

Plant Biologist’s Work Investigated

Institutions where RNA interference scientist Olivier Voinnet has worked are looking into allegations of misconduct.

Apr 2, 2015
Kerry Grens

WIKIMEDIA, HOFLIMultiple institutions are scrutinizing the work of Olivier Voinnet, a prominent RNA interference (RNAi) researcher at the Swiss Federal Institute of Technology (ETH) in Zürich, according to Lab Times. The investigations come after numerous posts on the post-publication peer review site PubPeer called foul on dozens of papers authored by Voinnet and his colleagues.

ETH-Zürich confirmed to Lab Times that an investigation into the allegations of image manipulation was underway. The CNRS Institute for Plant Molecular Biology in Strasbourg, France, where Voinnet previously worked, also indicated that it was beginning an investigation into the researcher’s work. And Cyril Zipfel, head of the Sainsbury Laboratory in Norwich, UK, where Voinnet earned his PhD, wrote on PubPeer: “We are actively discussing with all other institutions concerned to define the best way forward to co-ordinate efforts to clarify how these irregularities occurred and to take appropriate measures.”

According to Lab Times, numerous coauthors of Voinnet said the figures in question were Voinnet’s responsibility. And in a comment posted to PubPeer yesterday (April 1), Vicky Vance, who studies RNA at the University of South Carolina, offered her perspective reviewing a 2004 Plant Cell paper by Voinnet and colleagues. According to Vance, the paper had been rejected by two other journals first (she was a reviewer on all three submissions), and each time, the same data were represented in different ways. “So basically, I don’t believe anything from that lab since that time,” Vance wrote. “Perhaps some of the results are true (probably many of them are), but there is no way to tell which ones are just random made-up data to support Voinnet’s view of the world.”

While he declined an invitation by Lab Times to comment, Voinnet has posted replies to papers questioned on PubPeer, declaring that he, too, is investigating the alleged problems. “My apologies for not having detecting this error before the paper was submitted,” Voinnet wrote in response to accusations of data manipulation in the 2004 Plant Cell paper. Additionally, as Retraction Watch reported in January, Voinnet is working to issue corrections on several of his papers. 

Some of the questioned papers were coauthored by David Baulcombe, a plant geneticist who is now at the University of Cambridge. Baulcombe has pledged to work transparently to address the concerns, he told Lab Times, and to ensure that “the various co-authors of the papers are not disadvantaged and that the relevant areas of science can move on.”

Update (April 7): Upon Voinnet's request, Plant Cell is considering a retraction of the 2004 study, according to Retraction Watch. In a statement released April 6, the journal confirmed that a reviewer had expressed serious concerns about the paper. "The corresponding author, Dr. Olivier Voinnet, provided a detailed response to the reviewer's allegations which, at the time, satisfied both the Editor-in-Chief and the Co-Editor. A new manuscript was later submitted and accepted after peer review."

Update (April 8): Vance has published her review of Voinnet's 2004 Plant Cell paper. In it, she details her concerns about the reliability of the data, stating: "The nature of the discrepancies between the first two versions of the manuscript led me to doubt the authenticity of the work and, frankly, the integrity of the authors. In the current Plant Cell version of the paper, some of the same problems remain and I continue to doubt the validity of some of the presented data." (Hat tip: Leonid Schneider)

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.